Latest CDC warning, a reminder that OTC products are not immune from safety issues
Whilst assessing Clinical Trials and Products Liability Insurance risks in the Life Science Industry, its a fairly common assumption that...
Contributors
-
PI Broker
-
Senior Vice President
-
Director of M&A
-
Director of M&A -
Trainee Broker - Cyber & Technology -
Partner and Head of Technical
-
Account Executive
-
Junior Broker -
Broker
-
Head of International Healthcare -
Director
-
Claims Account Executive -
Direct of UK FI -
Partner -
Cyber and Technology Broker
-
Vice President -
Partner & Head of UK Professions -
Senior Vice President -
Life Science Broker -
SVP Healthcare & Life Science -
Healthcare Broker
-
Partner -
Senior Vice President -
Partner -
Senior Vice President -
Managing Principal
-
Partner and Head of Cyber -
Senior Vice President -
IT Manager -
Partner & Director
-
Partner
Paragon Archive
- March 2023 (1)
- February 2023 (2)
- January 2023 (1)
- November 2022 (2)
- October 2022 (2)
- September 2022 (4)
- August 2022 (6)
- July 2022 (8)
- June 2022 (2)
- May 2022 (8)
- April 2022 (7)
- March 2022 (10)
- February 2022 (3)
- January 2022 (10)
- December 2021 (4)
- November 2021 (9)
- October 2021 (8)
- September 2021 (9)
- August 2021 (10)
- July 2021 (15)
- June 2021 (13)
- May 2021 (3)
- April 2021 (11)
- March 2021 (20)
- February 2021 (38)
- January 2021 (6)
Antibiotic Shortage highlights common drugs are not immune to economic issues
It’s a fairly common trait for most of us to seek antibiotics when we contract an infection or have a less than mild cough and cold....
Soft Tissue Market Continues to Thrive
For most of us, when we consider what the human body consists of and how we function, we often think about the main organs (brain, heart,...
Alzheimer’s Drug lecanemab Showing Promising Results In Clinical Trials
A new investigational drug, from Eisai and Biogen, has shown promising results for slowing progression of cognitive decline during Phase...
Mass General Brigham Suffers Q3 Net Loss Of $949m
Mass General Brigham suffered a net loss of $948m in Q3, a huge contrast to Q3 last year, which saw an $870m net gain.
The recent loss,...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net